National and Kapodistrian University of Athens
Μοριακή ανάλυση των μεταλλάξεων του PIG-A γονιδίου στις νόσους ανεπαρκείας του μυελού των οστών
Abstract
dc:descriptionAcquired bone marrow failure syndromes characterized by aplastic orhypoplastic bone marrow namely, acquired aplastic anaemia (AA),paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes(MDS), seem to share common pathophysiological mechanisms andincreased genetic instability and mutation frequency. Despite the variableclinical course of AA and PNH, many patients evolve to MDS and acutemyeloid leukemia (AML). We studied the incidence of a PIG-A specificmutational hot spot -5bp deletion GTACT-, FLT3-ITD mutation, and NPM1mutations in blood and bone marrow samples from 1 AA patient and 1AA/PNH patient, 17 PNH patients, 85 MDS patients, 24 AML patients, 16chronic myeloid leukemia (CML). Bone marrow DNA was available in 14transformed patients, both in MDS stage and AML transformation. We alsoscreened DNA samples, extracted from peripheral blood of 48 healthy donors.PIG-A 5bp deletion was detected after first round PCR only in 3 PNH patient.Using the semi-nested PCR approach we found positive the AA/PNH patient,and 4/17 PNH patients (3 were positive from first round PCR), 9 positivesamples out of 48 in healthy individuals (18.75%), 14/85 in MDS samples(16.5%). From the 14 paired MDS/AML samples, one was positive in MDSstage but the mutation was not detected after transition to AML. One sample,tested negative during the MDS phase of the disease, was found positiveduring transition to AML. Positive FLT3-ITD samples were not seen in AA,AA/PNH, PNH and CML patients. In contrast positive FLT3-ITD samples were detected in 8/85 MDS patients (9.41%) and 10/24 AML patients (41.67%).From the 14 paired MDS/AML samples, 3 were FLT3-ITD positive in MDSstage and the mutation was still detected after transition to AML. One sample, tested FLT3-ITD negative during the MDS phase of the disease, was foundpositive during transition to AML. NPM1 mutations were detected only in 2 denovo AML patients simultaneously with FLT3-ITD mutation and in one CMLpatient in complete molecular response during imatinib therapy. Finally wetried to identify if a common pattern of genomic changes occur in differentMDS patients during their transformation to AML, using chromosomal-Comparative Genomic Hybridization (ch-CGH). A common pattern ofchromosomal loci gains was shared between MDS patients during AMLtransformation. The finding of common chromosomal loci gains duringtransition of MDS to AML is extremely important, given the wide clinical andgenetic heterogeneity of MDS patients. Further studies, to document ifincreased gene dosage results in enhanced transcription/translation and thuscontributes to leukemogenesis, have to be done. Furthermore, this study demonstrates that PNH+ cells if present in bone marrow failure syndromesare not the one selected for blast cell evolution during transformation to AML.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Efthymiou, Anna
- Ευθυμίου, Άννα
Subjects
dc:subject × 16- Μυελοδυσπλαστικά σύνδρομα (ΜΔΣ)
- Παροξυσμική νυχτερινή αιμοσφαιρινουρία (Π.ΝΑ)
- Απλαστική αναιμία (ΑΑ)
- Σύνδρομα ανεπαρκείας του μυελού των οστών
- Μεταλλάξεις του PIG-A
- Myelodyoplastic syndromes (MDS)
- Paroxysmal nocturnal haemoglobinuria (PNH)
- Aplastic Anemia (AA)
- Bone marrow failure syndromes
- PIG-A mutations
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41387